Hacker News
- MDMA-assisted therapy for PTSD: A randomized, placebo-controlled phase 3 trial https://www.nature.com/articles/s41591-023-02565-4 104 comments
- MDMA-assisted therapy for moderate to severe PTSD https://www.nature.com/articles/s41591-023-02565-4 2 comments
- MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://www.nature.com/articles/s41591-023-02565-4 76 comments science
Linking pages
- Psychedelics Are Challenging the Scientific Gold Standard - The Atlantic https://www.theatlantic.com/health/archive/2024/06/psychedelics-mdma-ptsd-fda-placebo/678588/ 229 comments
- Book Review: The Long, Strange History of MDMA https://undark.org/2023/09/22/book-review-the-long-strange-history-of-mdma/ 140 comments
- MDMA—aka ecstasy—submitted to FDA as part of PTSD therapy | Ars Technica https://arstechnica.com/science/2023/12/mdma-aka-ecstasy-submitted-to-fda-as-part-of-ptsd-therapy/ 28 comments
- Crenshaw's Psychedelic Research Provision Signed into Law | Press Releases | Congressman Dan Crenshaw https://crenshaw.house.gov/2023/12/crenshaw-s-psychedelic-research-provision-signed-into-law 25 comments
- VA to begin researching psychedelics as treatment option for veterans - Government Executive https://www.govexec.com/management/2024/01/va-begin-researching-psychedelics-treatment-option-veterans/393138/ 12 comments
- MDMA Therapy for PTSD Inches Closer to U.S. Approval - The New York Times https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html 8 comments
- FDA’s review of MDMA for PTSD highlights study bias and safety concerns | Ars Technica https://arstechnica.com/science/2024/05/fdas-review-of-mdma-for-ptsd-highlights-study-bias-and-safety-concerns/ 7 comments
- FDA Panel Rejects Use of MDMA for Treatment of PTSD - The New York Times https://www.nytimes.com/2024/06/04/health/fda-mdma-therapy-ptsd.html 6 comments
- FDA Declines to Approve MDMA Therapy, and Seeks Further Study - The New York Times https://www.nytimes.com/2024/08/09/health/fda-mdma-ptsd-delay.html 4 comments
- MAPS seeks approval of Ecstasy- or MDMA-assisted therapy - The Washington Post https://www.washingtonpost.com/business/2023/12/12/mdma-therapy-fda-maps/ 1 comment
- FDA advisors voted against MDMA therapy – researchers are still fighting for it https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it 1 comment
- Opinion | How the Psychedelics Medicine Bubble Burst - The New York Times https://www.nytimes.com/2024/08/23/opinion/psychedelics-mdma-mental-health.html 1 comment
- MAPS PBC Announces Publication of Results from Confirmatory Phase 3 “MAPP2” Trial of MDMA – Assisted Therapy for PTSD in Nature Medicine | MAPS Public Benefit Corporation https://mapsbcorp.com/news/mdma-assisted-therapy-for-ptsd-phase-3-results-publication-in-nature-medicine/ 0 comments
- Ecstasy’s bid for FDA approval reveals challenges of psychedelic trials - The Washington Post https://www.washingtonpost.com/health/2024/04/27/mdma-ecstasy-therapy-fda-psychedelic/ 0 comments
- As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence https://text.npr.org/1250580932 0 comments
- America holds back MDMA therapy - UnHerd https://unherd.com/newsroom/america-holds-back-mdma-therapy/ 0 comments
- How the FDA Could Shape the Future of Psychedelics Research https://undark.org/2024/08/05/fda-future-of-psychedelics-research/ 0 comments
- FDA does not approve MDMA therapy in a surprising blow to the psychedelic renaissance | Vox https://www.vox.com/future-perfect/365820/mdma-therapy-lykos-therapeutics-maps-psychedelics-ecstasy 0 comments
Linked pages
Related searches:
Search whole site: site:nature.com
Search title: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine
See how to search.